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ABSTRACT 
Oculocardiac reflex (OCR) has been described to occur with mechanical manipulation of the eye, eyelids or orbit. There 
are no reports in the literature of OCR during intravitreal injection (IVI). This may be due to the fact that heart rate is not 
monitored during the procedure. We aimed to evaluate OCR during IVI. A total of 532 patients were enrolled in the study 
at Asociacion para Evitar la Ceguera en Mexico. Mexico City, Mexico. IVI was performed on one eye in every patient with 
diabetic retinopathy (DR), age related macular degeneration (AMD) or choroidal neovascularization (CNV) secondary to 
pathological myopia. Heart rate was monitored with a pulse oximeter before, during and after injection. OCR was 
defined as a 20% decrease or more of basal heart rate. The population enrolled included 270 females and 262 males with 
mean age of 63.8 years. A decrease in heart rate of 20% or more occurred in 18 patients during IVI (3.3%; 95% 
confidence interval 1.85% and 4.92%). OCR was asymptomatic in these patients. OCR occurred in 3.3% of our patients 
during IVI. Hence, OCR must be considered when performing IVI. 
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INTRODUCTION
The oculocardiac reflex (OCR) is a sudden onset 
bradycardia that occurs sometimes during mechanical 
manipulation of the eye, eyelids or orbit. The afferent 
pathway comes from the ophthalmic branch of the 
trigeminal nerve. The efferent pathway is carried by the 
vagus nerve, which is accountable for the vagally 
mediated response of bradycardia [1-3]. Although sinus 
bradycardia is the most frequent effect of OCR, 
arrhythmia and asystole have been reported as well [4-
7]. OCR occurs more frequently in children, especially 
during strabismus surgery [8-11] , it can also occur in 
adults [12, 13] and it has been described in a large variety 
of ophthalmic procedures [14-24]. 
The intensity of OCR decreases after repeated stimuli 
[25]. It is a fatigable reflex. Retrobulbar block [26], the 
use of anticholinergics [27-29] and deeper general 
anesthesia [10, 30, 31] can help reduce the occurrence of 
OCR. On the other hand, when fast-acting opioids [32, 
33] or dexmedetomidine [34, 35] are used, they can 
increase OCR. 
Intravitreal injection (IVI) of anti-vascular endothelial 
growth factor (VEGF) [36-40] and other drugs [41-44] is 
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now the most frequent procedure performed in 
ophthalmology [45]. IVI of anti-VEGF is commonly used 
to treat a variety of retinal conditions, such as age 
related macular degeneration and diabetic retinopathy 
[39, 46-51]. It is estimated that 5.9 million IVI were 
performed in the United States in 2016 [45]. 
The purpose of this study was to evaluate OCR during IVI. 
MATERIALS and METHODS 
During a 30-day period (June 2019), 532 patients 
scheduled for IVI were included for this study at the 
Asociacion para Evitar la Ceguera en Mexico (APEC) in 
Mexico City. The study complied with the Declaration of 
Helsinki. A written informed consent was obtained from 
all patients. This study received an ethical approval from 
our academic center. Only one eye of each patient was 
considered for the study. Patients taking medication for 
arrhythmia or having a pacemaker were excluded, all 
other patients were included. All injections were 
performed in the supero-temporal quadrant location. 
Injections were done following the 2018 consensus 
protocol recommendations [43]. The IVI was achieved in 
a sterile fashion (Figure 1). Heart rate was measured with 
a pulse oximeter (Zacurate, The USA) before and after 
placing the eyelid speculum, during the injection and 
after removing the speculum. 
 
 
Figure 1. Superotemporal Intravitreal Injection in a Sterile Fashion in 
the Left Eye. 
 
Statistical analysis 
The percentage of patients with a decrease of 20% or 
more in basal heart rate was calculated using 
programming language R [52-54].   
RESULTS 
As shown in Table 1, of 532 eyes studied, 262 were 
males and 270 females, with a mean (range) age of 
63.8 (29 – 89) years and 247 IVI in the right eye (OD) 
and 285 in the left eye (OS). Indications for IVI were 
respectively diabetic retinopathy (DR) in 352 eyes, age 
related macular degeneration (AMD) in 177 and 
choroidal neovascularization (CNV) secondary to 
pathological myopia in 3. In terms of the type of drug 
injected, 340 eyes received Ranibizumab (Lucentis; 
Genentech, The USA), 186 eyes Aflibercept (Wetlia; 
Bayer, Germany) and 3 eyes Ozurdex implant by IVI 
(Allergan, The USA; Dexamethasone intravitreal 
implant), respectively. Regarding OCR, of 532 patients 
enrolled, 18 presented a decrease in basal heart rate 
of 20% or more (Table 2 and Figure 2). As shown in 
Table 2, of 18 eyes, 12 were males and 6 females with 
a mean (range) age of 63.2 (41-84) years and 8 IVI in 
the OD and 10 IVI in the OS. Indications for IVI in these 
18 patients were DR in 10 eyes, AMD in 6 eyes and 
CNV secondary to pathological myopia in 2 eyes. 
Ranibizumab was injected in 10 eyes and Aflibercept in 
8 eyes. Statistical analysis showed a 3.3% incidence for 
OCR during IVI. A 95% confidence interval (CI) was 
found to be (1.85% and 4.92%). However, all patients 
with OCR were asymptomatic. 
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Table 1. Demographic Characteristics of the Study Subjects 
Abbreviations: n: number of eyes; OD: right eye; OS: left eye; IVI: intravitreal injection; DR: Diabetic Retinopathy; AMD: age related macular 
degeneration; CNV: choroidal neovascularization secondary to secondary to pathological myopia; Ranibizumab: Lucentis (Genentech, The USA); 
Aflibercept: Wetlia (Bayer, Germany); Ozurdex: (Allergan, The USA) Dexamethasone intravitreal implant. 
 
Table 2. A Summary of Characteristics of Patients With OCR During IVI 
No. Sex; F/M Age; Y Basal HR IVI HR Name of Medication Side Diagnosis 
1 F 55 86 63 Aflibercept OD DR 
2 F 84 91 69 Ranibizumab OS DR 
3 F 63 89 65 Aflibercept OD DR 
4 F 60 75 57 Aflibercept OD AMD 
5 F 50 92 73 Aflibercept OS DR 
6 F 59 85 65 Ranibizumab OS DR 
7 M 76 92 64 Aflibercept OS AMD 
8 M 41 95 75 Ranibizumab OD CNV 
9 M 56 105 82 Ranibizumab OD DR 
10 M 62 89 69 Ranibizumab OD DR 
11 M 64 86 66 Aflibercept OS DR 
12 M 54 89 68 Ranibizumab OS DR 
13 M 60 99 66 Ranibizumab OS CNV 
14 M 77 81 62 Aflibercept OD AMD 
15 M 74 63 49 Ranibizumab OS AMD 
16 M 65 84 58 Aflibercept OS DR 
17 M 71 73 57 Ranibizumab OD AMD 
18 M 67 82 61 Ranibizumab OS AMD 
Abbreviations: F: female; M: male; Y: years; HR: heart rate; IVI: intravitreal injection; OD: right eye; OS: left eye; DR: Diabetic Retinopathy; AMD: age 
related macular degeneration; CNV: choroidal neovascularization secondary to pathological myopia; Ranibizumab: Lucentis (Genentech, USA); 
Aflibercept: Wetlia (Bayer, Germany). 
 
DISCUSSION 
In this study, OCR occurred in 3.3% of patients during IVI. 
All patients who had OCR were asymptomatic. OCR 
occurred in patients of both genders and all were over 40 
years. OCR occurred with both Aflibercept and 
Ranibizumab, both were the most frequent medications 
used in this study.  
OCR is more common in children, particularly during 
strabismus surgery, although other studies have shown 
that OCR can occur in adults [13]. Using 
electrocardiogram, in 1998 we published a series of adult 
patients with OCR during Laser-Assisted In Situ 
Keratomileusis (LASIK) [13]. In patients with OCR, 
decrease in heart rate appeared when the suction ring 
(pressure) was applied; all patients who underwent LASIK 
and presented a decrease in heart rate during the 
procedure were asymptomatic.  
For the purpose of this study, we measured how many 
seconds it took to perform the IVI. For the experienced 
ophthalmologist, IVI took 10 seconds or less, in contrast 
with rectus muscle traction during strabismus surgery 
(minutes) [55, 56]. 
 
 
 
Age; range (years) 29 – 89 (mean 63.8) 
Gender; n Male 262 
Female 270 
Laterality; n OD 247 
OS 285 
Indication for IVI; n DR 352 
AMD 177 
CNV     3 
Injected Medication; n Ranibizumab 340 
Aflibercept 186 
Ozurdex     3 
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Figure 2. Basal Heart Rate (Heart Rate Before) and Heart Rate of Patients With Oculocardiac Reflex During Intravitreal Injection (IVI) 
 
OCR has been reported in 14% to 90% of patients during 
strabismus surgery [57]. Although OCR has been 
described in adult patients during different 
ophthalmological procedures [13, 20, 58], it is more 
common in children. Muscle traction during strabismus 
surgery and muscle entrapment in blowout fractures [59-
62] of the orbit are the two most common circumstances 
associated with OCR. Individual cases of OCR during 
different procedures in adults under local anesthesia 
could be seen as anecdotal, but the ophthalmologist 
must be aware of its possible occurrence.  
We assume that in this study OCR was asymptomatic 
because of the short duration of the procedure [63-65]. 
The “2018 Update on Intravitreal Injections: Euretina 
Consensus Recommendations” addresses important 
issues related to pre-injection, peri-injection and post-
injection management [45]. The authors stated that “the 
ophthalmologist should be aware of the potential 
cardiovascular and cerebrovascular risks of these 
agents”. Unusual systemic events after anti-VEGF IVIs 
have been reported, such as visual hallucinations, 
erectile dysfunction and acute decrease in kidney 
function [45] The role of anti-VEGF in these instances 
remains to be established. 
After a comprehensive PubMed search, we could not find 
any report in the literature concerning OCR and IVI. This 
is because heart rate is not monitored during IVI and 
therefore not detected. A similar situation occurred 
during LASIK, OCR was not considered until heart rate 
was monitored during the procedure [13, 31]. This is the 
first report of OCR during IVI. Although our study 
included over 500 patients, it was single center, and 
compromised three types IVI and three medications. 
Therefore, further multicentric studies with more sample 
size, and wide range of injected medications and 
indications, must be done to confirm our findings.  
CONCLUSION 
In conclusion, OCR occurred in 3.3% of patients during 
IVI. Hence, OCR must be considered when performing 
IVIs. 
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